Magnitude Biosciences Ltd

An innovative C. elegans company, using our expertise and technology to provide quantified non-invasive assays of health outcomes for biotech, nutrition and other industries and research interests. - Prescreen compounds to reduce the number of experiments in mammals - Find effective and safe concentration ranges - Test mutants in signalling pathways - Screen libraries of mutants - Screen compound libraries - Combine compounds and mutants - Adapt technology to address your questions We are a team of experts with a proven track record of: Designing customised C. elegans studies to provide answers to your specific ageing research questions Integrating C....

Ageing,screening,drug discovery and validation,cro,aging,microbiome,toxicity,neurodegeneration,c. elegans,in vivo assays,and healthspan

Magnitude biosciences ltd operates in the Biotechnology research industry.

Magnitude biosciences ltd's revenue is 11m - 100m

Magnitude biosciences ltd has 11 - 50 employees.